发明名称 |
Methods and Apparatus for Treating Obesity and Diabetes |
摘要 |
Provided herein are methods and shunt devices for treating diabetes and obesity. Methods and shunt devices promote stimulation of secretion of intestinal L-cells and other enteroendocrine cell types. Enteroendocrine secretion is stimulated directly or indirectly by shunting bile and/or pancreatic secretion to segments of the gut more distal than would normally occur. The shunt device may be a flexible catheter that is impervious to such secretions, with a proximal end draining the pancreatic/bile duct, and a distal end residing distally within the lumen of the small or large intestine. The shunt may be inserted with minimally invasive techniques, such as by endoscopy or laparoscopy.
|
申请公布号 |
US2013090590(A1) |
申请公布日期 |
2013.04.11 |
申请号 |
US201213689577 |
申请日期 |
2012.11.29 |
申请人 |
SATIOGEN PHARMACEUTICALS, INC.;SATIOGEN PHARMACEUTICALS, INC. |
发明人 |
YOUNG ANDREW A.;GEDULIN BRONISLAVA;GREENE HOWARD E.;AYLING ROBERT;YUREK MATTHEW |
分类号 |
A61M27/00;A61F2/04 |
主分类号 |
A61M27/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|